SCHEMBL21132162

SCHEMBL21132162

CCCC(CCI)OCC

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.35
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30171 0.92 THRB (0.40) THRBLMNA
SCHEMBL22654527 0.87 THRB (0.44) THRBLMNA
SCHEMBL11004515 0.80 THRB (0.35) THRBLMNA
SCHEMBL11606263 0.79 DNM1 (0.41)
SCHEMBL11290325 0.77
SCHEMBL1877496 0.76
SCHEMBL11004533 0.75 THRB (0.35) THRBLMNA
SCHEMBL11719323 0.75 MEN1 (0.35) THRBLMNA
Hydrogen Sulfide SCHEMBL27817780 0.74 THRB (0.38) THRBLMNA
SCHEMBL3802704 0.73 OPRM1 (0.42) THRBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10336717-B2 Inhibitors of beta-secretase VITAE PHARMACEUTICALS, LLC (US) 2019-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10336717-B2 Inhibitors of beta-secretase BACE1, BACE2, PSEN1 THRB 2578/4885LMNA 521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.